Choongsoon Bae

Engineering Partner

Scott Biller

Executive Venture Partner

Brendan Bulik-Sullivan

General Partner

Sherry Chao

Principal

Frederique Dame

Partner

Karim Faris

General Partner

Catherine J. Friedman

Executive Venture Partner

Anika Gupta

Principal

Crystal Huang

Partner

Tom Hulme

General Partner and Head of Europe

Rosana Kapeller

Entrepreneur In Residence

John Lyman

Partner

Laura Melahn

Partner

Erik Nordlander

General Partner

David Reshef

Venture Partner

Vidu Shanmugarajah

Partner

M.G. Siegler

General Partner

Jon Stritar

Engineering Partner

Andy Wheeler

General Partner

Jeremy Whelchel

Engineering Partner

Sangeen Zeb

Partner

Past deals in North America

Comanche Biopharma

Venture Round in 2023
Comanche is a biopharmaceutical company developing an investigational siRNA medicine for preterm preeclampsia. We envision a world where all women and their babies have access to safe and effective therapies for treating life threatening complications of pregnancy, and those solutions must be evidence-based and affordable.

AMP

Series C in 2023
AMP is an AI technology company that modernizes recycling infrastructure through smart sortation solutions. The company focuses on maximizing resource recovery while minimizing labor costs for waste management operations. With numerous deployments globally, AMP aims to transform the economics of recycling.

Cerevance

Series B in 2023
Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases, including chronic neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and amyotrophic lateral sclerosis. Using a large and growing repository of over 15,000 human brain tissue samples, the company generates an unprecedented level of expression and epigenetic data, enabling the company to identify the most promising targets for the next generation of treatments for CNS disorders.

Jetpack

Seed Round in 2023
Jetpack creates scalable cloud backend software for engineers to help them with coding and cloud services. The platform develops software that builds scalable web backends for the cloud and creates images and configurations directly from annotated python code.

Galileo

Series D in 2022
Galileo provides high-touch, data-driven, multi-specialty, longitudinal care to a diverse and complex patient population—over the phone, at home, and everywhere in between. Regional and national health plans, employers, and Fortune 500 companies all regard Galileo as the leading solution for improving population health. It aims to use that talent and scientific thinking to transform society by solving the most difficult healthcare problems while also bringing patients and providers closer together.

Flatfile

Series B in 2022
Flatfile, the pioneer of AI-assisted data exchange, provides companies and software development teams with the easiest, fastest, and safest way to build an ideal data file import experience for users. Hundreds of companies such as AstraZeneca, Square, and Sage rely on Flatfile’s extensible, API-first platform to create enterprise-scale, intelligent, file-based data import solutions, increase developer productivity, reduce cost, and improve data quality.

Sardine

Series B in 2022
Sardine specializes in providing risk management solutions primarily for the financial services sector. They focus on using artificial intelligence and machine learning to help enterprises manage risks associated with fraud, credit, and compliance. The company aims to serve businesses in the digital economy by offering tools and services that enhance operational efficiency and ensure regulatory compliance.

Pretzel Therapeutics

Series A in 2022
Pretzel was founded by some of the world’s foremost academics in mitochondrial biology, and we benefit from the leadership of accomplished experts in drug discovery, drug development, and company formation. Our name is inspired by the focal point of our science, the mitochondrion, whose highly folded inner membrane is one of many fascinating features that make it unlike any other organelle in the body.

Omni

Series A in 2022
Omni is the only BI platform that combines the consistency of a shared data model with the freedom of SQL. The company aims to enhance business intelligence, making it faster, and flexible while avoiding unnecessary complexity. With Omni no need to compromise. Omni balances the consistency of a shared data model with the freedom of SQL, so you can focus on answering your most important questions and driving business impact with data.

Fractyl Health

Series F in 2022
Fractyl Health develops innovative medical device solutions for the treatment of chronic diseases. The growing product pipeline leverages our minimally invasive procedural therapy, Revita DMR (duodenal mucosal resurfacing), which is designed to rejuvenate the lining of the duodenum and improve patient health. They envision a world with better solutions to chronic diseases through the use of less invasive, device-based therapies that will lessen the burden on patients, physicians, and payers. Fractyl Health aims to bring curative therapies to the large populations of patients with metabolic disease.

Vicinitas Therapeutics

Series A in 2022
Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives. Its vision is to use its proprietary Deubiquitinase Targeting Chimera (DUBTAC) platform to restore the levels of aberrantly degraded proteins that cause disease to confer therapeutic benefit.

Xilis

Series A in 2022
Xilis is a biotechnology company that develops technologies to guide precision therapy for cancer patients and accelerate drug discovery. The company's platform enables diagnostics, drug screening, and scalable patient-derived models for drug discovery, enabling physicians and pharmaceutical companies to develop tailored treatments for patients by conducting drug screening.

Merlin Labs

Series B in 2022
Merlin Labs is building an autonomous infrastructure for the sky above us, enabling goods and eventually people, to fly without pilots. It specializes in the fields of software, transportation, and information technology. The company was founded in 2018 and is headquartered in Boston, Massachusetts.

Areteia Therapeutics

Series A in 2022
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease. The company was spun out of Pennsylvania-based Knopp, which published results from its phase 2 clinical trial last year that showed its oral drug candidate could reduce the count of blood eosinophil, which is an indication of improving lung function and is found in several asthma-related treatments.

SingleStore

Series F in 2022
SingleStore is a provider of a database for operational analytics and cloud-native applications. It provides global enterprises with an intelligent database that works on any cloud on-premises or as a service runs transactions and analytics at the same time and lets clients promote their business through analytics and combine semi-structured data into a consolidated big data platform.

FYTO

Series A in 2022
FYTO provides personalized solutions that improve the economic and environmental sustainability of agriculture for farmers around the world. FYTO specializes in developing crops that have ultra-high yields and ultra-low resource requirements, cultivation and harvesting systems for quality and consistency, climate-friendly methodologies for resiliency and long-term sustainability, and a range of groundbreaking agricultural products such as animal feed and biofertilizers.

Modular

Seed Round in 2022
Modular is an AI software developer platform that unifies the development and deployment of AI for everyone. The product breakthroughs will be powered by production quality infrastructure that brings together compilers and runtimes, is designed for heterogeneous computing, edge to datacenter distribution, and is focused on usability. Unifying software and hardware with a "just works" approach will save developers enormous time and increase their velocity.

Sanas

Series A in 2022
Sanas is a real-time speech-understanding platform that modulates accents while preserving voices and emotions for natural interactions. The platform assists multilingual speakers with accent correction, allowing them to communicate effectively without language barriers. Sanas's technology is utilized by contact centers and enterprises to enhance communication, improve customer satisfaction, and reduce miscommunication.

Courier

Series B in 2022
Courier provides an API that enables developers to manage and route user notifications across various communication channels, such as email and messaging platforms. By leveraging user engagement data and online status, the API optimizes notification delivery, ensuring that messages reach users through the most effective medium. The company's notification management software allows clients to create reusable messages that can be customized for different channels, facilitating timely and targeted communication. Over the years, Courier has adapted to technological advancements while maintaining a stable management approach, emphasizing the importance of customer success. The company has developed long-lasting relationships with its largest clients, continually collaborating to meet their evolving needs.

Ahana

Series A in 2022
Ahana focused on bringing PrestoDB-based ad hoc analytics offerings to market and working to foster growth and evangelize the Presto community. While Presto is in large-scale production deployment at large internet companies like Facebook, Uber, and Twitter, Ahana’s mission is to simplify ad hoc analytics for organizations of all shapes and sizes.

Sesame

Series B in 2022
Sesame is an award-winning company that offers Americans quality, convenient health care at half the typical price. The company's AI-enabled marketplace eliminates insurance, allowing healthcare providers to compete on quality, accessibility – and pricing. It is the official telehealth partner of Costco.

Nava

Series B in 2022
Nava is a new kind of benefits brokerage on a mission to bring high-quality, affordable healthcare to employers and their employees. It offers healthcare tools, year-round employee advocacy, and ongoing measurement to monitor and recommend healthcare plans, thus enabling clients to provide the required benefits to their employees while lowering overall plan cost.

Strella Biotechnology

Series A in 2022
Strella biotech is a revenue-generating food supply chain company that provides data to optimize the produce supply chain via patented proprietary sensing technology. It specializes in the fields of supply chain management and big data. Strella was founded in 2018 by Jacob Jordan and Katherine Sizov and is based in Philadelphia, Pennsylvania, United States.

FarmWise

Series B in 2022
FarmWise provides technology-based services that allow farmers to streamline farm operations and increase food production efficiency. It offers a productive mechanical weeding implement for vegetable crops, along with its exceptional training and support program. The company was founded in 2016 and is based in San Francisco, California.

Gametime

Venture Round in 2022
Gametime sells last-minute tickets to the most popular events in sports, music, and theater. It makes finding the perfect live experience remarkably fast and easy. They curate an epic list of the most amazing possibilities in the city has to offer. Once the client selects their event it will examine over 10,000 potential seats and present them with the 50 best values to select. Each curated seat option includes a panoramic high-resolution photo so their client can experience the actual view from their section. Navigate to the seat map to see price versus the location comparisons with true-to-life, full-color venue maps. Gametime delivers the tickets directly to the client's phone. Now they are offering sports, concerts, and theater events across the United States and Canada.

Graft

Pre Seed Round in 2022
Graft is a Modern AI platform enabling data teams to build production-ready AI solutions in a few clicks. No machine learning skills, no need to hire a team, and no infrastructure to build or maintain. Take a data-centric approach that leverages foundation models to drive better business outcomes today.

Invetx

Series B in 2022
Invetx is a veterinary therapeutics company that develops protein-based therapeutics for animal health. Invetx's network includes animal and human health experts, veterinary scientists, and clinicians. The company's vision is of a global animal health industry that fully leverages biopharma technologies to deliver dramatically improved health outcomes for pets and farm animal populations.

Aspen Neuroscience

Series B in 2022
Aspen Neuroscience is a development stage and private biotechnology company that uses innovative genomic approaches combined with stem cell biology to deliver patient-specific, restorative cell therapies that modify the course of Parkinson's disease. It is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical needs, beginning with autologous neuron replacement for both sporadic and genetic forms of Parkinson's disease (PD) and extending across the brain and affected organs.

Viz

Series D in 2022
Viz helps physicians to identify anomalies in brain scans through machine learning. The company leverages advanced deep learning to communicate time-sensitive information about stroke patients straight to a specialist who can intervene and treat them. It uses deep learning algorithms to identify a suspected large vessel occlusion, a particularly disabling type of stroke, in a CT scan and alerts the stroke team specialist within minutes. Viz has developed deep learning algorithms to analyze brain scans for large vessel occlusions (LVOs), a disabling type of stroke. The company also allows the stroke center’s clinicians to rapidly share images back and forth. Viz's mission is to fundamentally improve how healthcare is delivered in the world, through intelligent software that promises to reduce the time to treatment and improve access to care. Viz was founded in 2016 and is based in San Francisco, California.

StackBlitz

Seed Round in 2022
StackBlitz is a developer of an integrated software used to offer comprehensive facilities to computer programmers for software development. Its software consists of a source code editor, build automation tools, and a debugger for creating sharing live projects that enable clients to get started with angular or react project without the need to deal with the installation of dependencies. The company also allows the developer to edit offline and tweak the application in real-time without page refresh and preserving the application state.

Rattle

Series A in 2022
Rattle develops a Salesforce integration technology allowing systems and people to interact with each other natively in Slack or Teams. It is a revenue orchestration platform that services all customer-facing departments in an organization. It lets sales representatives log their calls, track key metrics, and update opportunities. Additionally, it makes AEs and SDRs update customer relationship management and gets real-time visibility and review pipeline reports helping marketing professionals to spend time only with their customers and not on internal process management. Rattle was co-founded in 2020 by Sahil Aggarwal, Apoorva Verma, and Milan Singh.

Obsidian Security

Series C in 2022
Obsidian Security creates a comprehensive and contextual understanding of these complex, interconnected applications to make them safer and secure. It is a threat detection and posture management for business-critical saas applications.

Brightline

Series C in 2022
Brightline is a technology-enabled behavioral health home for children and their families. Brightline delivers integrated care through innovative technology, virtual behavioral health services, and a collaborative care team focused on supporting children across developmental stages and their families. The company was founded in 2019 and is based in Palo Alto, California.

Celsius Therapeutics

Series B in 2022
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients. The company is a group of scientists, technologists, computational biologists, clinicians, and drug hunters who use single-cell genomics and machine learning analysis to find new drugs. Celsius Therapeutics was founded in 2018 and is headquartered in Cambridge, Massachusetts.

Digits

Series C in 2022
Digits is a fintech company building tools for businesses and finance professionals by leveraging its proprietary Living Model technology. The company was founded by Wayne Chang and Jeff Seibert in 2018 and is headquartered in San Francisco, California, United States.

LifeMine Therapeutics

Series C in 2022
LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines. LifeMine’s Avatar-Rx platform integrates high-throughput microbiology, data science and machine learning, genome engineering, and automation technologies to search the fungal biosphere for novel GEMs having a predetermined target and biological function. The platform integrates chemoinformatic-assisted drug optimization and state-of-the-art chemical synthesis with biotransformation to advance new product candidates into development. Founded by Gregory Verdine, PhD, Rick Klausner, MD, and WeiQing Zhou, MBA. LifeMine Therapeutics is headquartered in Cambridge, Massachusetts.

Spotlight Therapeutics

Series B in 2022
Spotlight Therapeutics is a developer of gene editing therapeutics intended to edit specific cell populations directly in the body. The company's therapeutics are used to create next-generation programmable nucleases that can selectively target and edit cells, enabling physicians to treat their patient in an enhanced way.

Agolo

Series A in 2022
Agolo does one thing exceptionally well: we turn messy, freeform unstructured product data into a clean entity graph-based data store that, in turn, powers many enterprise use cases. Use cases range from GenAI Apps to LLMs and RAG Pipelines to Business Intelligence Dashboards and Reports to Support Site Augmentation to Enterprise and Application Search. Taken together, the business impact is clear line of sight to your customers' product experience, leading to improved product quality, lower support costs, and faster detection of emerging issues.

DNAnexus

Series H in 2022
DNAnexus develops a cloud platform and global network designed for scientific collaboration and accelerated discovery. It provides security, scalability, and collaboration for enterprises and organizations that are pursuing genomic-based approaches to health in order to accelerate medical discovery. DNAnexus is supporting customers around the world that are tackling some of the most challenging and exciting opportunities in human health. The company was founded in 2009 and is based in Mountain View, California.

dbt Labs

Series D in 2022
Dbt Labs is a developer of an open-source analytics engineering tool driven by a mission to help analysts create and disseminate organizational knowledge. Its platform enables data analysts to easily create and disseminate organizational knowledge through data modeling, thereby allowing clients with SQL knowledge to build data transformation workflows. The company was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.

RightHand Robotics

Series C in 2022
RightHand Robotics provides end-to-end solutions that reduce the cost of e-commerce order-fulfillment of electronics, apparel, grocery. Their robots grasp a wide variety of items from bins and cases. Their core technology enables them to do this automatically without laborious data entry or parameter-tuning — so they are inexpensive to set up and flexible to the changing needs of businesses. The company was founded in 2015 and is headquartered in Somerville, Massachusetts.

Redpanda Data

Series B in 2022
Redpanda Data offers a Kafka API-compatible streaming platform that unifies historical and real-time data. It enables inline Lambda transformations, all exposed under a drop-in Kafka-API replacement.

Helium

Series D in 2022
Helium is an internet-of-things developer platform for building the network and transferring IoT device data. The platform builds the peer-to-peer wireless network to simplify connecting anything to the internet by rewarding anyone to become a network operator. It provides wireless coverage for low-power Internet of Things (IoT) devices and earns a new cryptocurrency, Helium, from your living room. Helium tokens by verifying network transactions, adding new blocks to the blockchain, and performing other tasks. The Proof-of-Coverage is a unique work algorithm that uses radio waves to validate that hotspots are providing legitimate wireless coverage.

Overview.ai

Series A in 2022
Overview’s inspection systems are built with Deep Learning technology which allows us to find mistakes more consistently and in a wider variety of situations.

Voltron Data

Seed Round in 2022
Voltron Data develops data access and memory computing tools to improve the existing data analytics ecosystem. The company focuses on making the data science ecosystem more efficient with modular and composable analytics building blocks.

Voltron Data

Series A in 2022
Voltron Data develops data access and memory computing tools to improve the existing data analytics ecosystem. The company focuses on making the data science ecosystem more efficient with modular and composable analytics building blocks.

Homebound

Series C in 2022
Homebound is a custom homebuilder that makes building the perfect home simple, transparent and human. Born out of the 2017 Northern California wildfires, Homebound was created by a local team of construction, real estate, design and technology experts who set out to create a better homebuilding solution for friends, family and neighbors affected. Homebound is the first homebuilder to manage the entire building process for homeowners and support them every step of the way — from insurance negotiation and architecture all the way to permitting, construction and move-in. Through easy-to-use technology and a network of vetted building experts, Homebound is simplifying the rebuilding process and alleviating the stress, complexity and uncertainty homeowners face after a natural disaster.

Neo.Tax

Series A in 2022
Neo.Tax is building the easiest and most accurate tax filing and automation software. Their first product simplifies the complex process of applying for the R&D tax credit, putting up to millions back into each company's pocket. With the recent tax law change to R&D capitalization, they've built the only product in the market developed to help companies understand this new change and optimize their tax liability. Each new product they've built solves acute pain points for virtually all finance teams from startups to public companies.

Ventus Therapeutics

Series C in 2022
Ventus Therapeutics is a biopharmaceutical company discovering and developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases, and cancer. Ventus' structural immunology platform offers unprecedented insight into mechanisms and molecular structures, combining core capabilities for precisely targeting the innate immune system: proprietary protein engineering capabilities that elucidate innate immune mechanisms, and leading-edge rational and structure-based drug design tools. Ventus has built an emerging pipeline of multiple drug programs addressing key targets in the innate immune system.

Seismic Therapeutic

Series A in 2022
Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using its IMPACT™ platform, the company is addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements of biologics drug discovery—structural biology, protein engineering, and translational immunology—to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has a pipeline of biologics to address adaptive immune system dysregulation and treat autoimmune diseases.

Scandit

Series D in 2022
Scandit is a technology platform for mobile computer vision and augmented reality (AR) solutions for enterprises. The company software brings unrivaled scanning performance to any app on any camera-equipped smart device, from smartphones to wearables to drones and robots - to read barcodes, recognize text and objects, and display real-time information as AR overlays. It helps consumers and employees find things on store shelves with their smartphones, and as things become more contactless. Organizations in retail, transport, logistics, and manufacturing use Scandit to power apps such as mobile shopping, self-checkout, inventory management, proof of delivery, and asset tracking. Use cases in healthcare include tracking patients, medication, specimens, and supplies. Scandit solutions take cost and time out of operations and improve employee and customer satisfaction. Clients include 7-Eleven, Alaska Airlines, Carrefour, Hermes, Johns Hopkins Hospital, La Poste, Levi Strauss & Co, Mount Sinai Hospital, Sephora, and Toyota.

Lacework

Venture Round in 2022
Lacework is a security platform for cloud generation that provides automated threat defense and intrusion detection for cloud workloads. Its platform automates every aspect of security, including configuration assessment, behavior monitoring, anomaly, and threat detection as well as incident investigation and provides continuous monitoring of all cloud components such as workloads, applications, processes, containers, machines, users, and accounts that enable security teams to protect data and workloads in the cloud and maintain continuous compliance. The company was founded in 2015 and is based in Mountain View, California.

Synapticure

Seed Round in 2022
Synapticure provides neurodegenerative disease patients with disease specialist and wrap around care, no matter where you live in the US. Founded by patients, we support Dementia, Parkinson's, ALS and more with everyone from on-demand disease-specific neurologists to SLT to 24/7 care coordination and support.

TenSixteen Bio

Series A in 2022
TenSixteen Bio is a biotechnology company focused on developing novel therapeutics for a variety of diseases. The company uses somatic mosaicism and clonal hematopoiesis (CHIP) to find and develop new treatments for age-related disorders. Foresite Labs co-founded TenSixteen Bio, which is based in San Francisco.

Censys

Series B in 2022
Censys provides an internet intelligence platform for threat hunting and exposure management. The company's platform gives organizations a comprehensive real-time view of global networks and devices to help businesses discover the devices, networks, and infrastructure on the internet.

Agtonomy

Seed Round in 2022
Agtonomy is a hybrid autonomous and tele-assist platform that specializes in advanced autonomous and AI solutions for agriculture. It focuses on addressing the pressing challenges of labor scarcity, sustainability, and shrinking profit margins faced by farmers. It partners with established equipment developers to transform tractors and agriculture machines into autonomous and remote-controlled equipment that is accessible to local farmers.

Verana Health

Series E in 2022
Verana Health is a digital health data company that delivers insights from unfiltered healthcare data with integrity to connect the dots between patient care and clinical research. Verana Health is exclusively entrusted by key specialty medical societies to manage data from real-world healthcare settings across more than 20,000 healthcare providers and 70 electronic health record systems. Its healthcare data ecosystem is powered by VeraQ™, a clinician-directed and AI-enhanced population health data engine that securely powers a data integrity feedback loop of nearly a half-billion raw, point-of-care health encounters. By applying advanced analytics to proprietary, curated datasets, Qdata™, Verana Health helps life sciences partners enhance evidence generation and speed clinical research that promote physicians’ quality of care and patients’ quality of life. For more information, visit www.veranahealth.com.

Cockroach Labs

Series F in 2021
Cockroach Labs, Inc. specializes in developing open-source database software, notably CockroachDB, which is a distributed SQL database tailored for modern cloud applications. Founded in 2015 and headquartered in New York, the company also has an office in Cambridge, Massachusetts. CockroachDB is designed to scale horizontally and can withstand various types of failures, including those at the disk, machine, rack, and datacenter levels, while maintaining minimal latency and no need for manual intervention. It supports strongly-consistent ACID transactions and offers an SQL API for data management. The software is suitable for diverse clients, ranging from startups to Fortune 500 companies, and is utilized for enterprise-grade disaster recovery services. CockroachDB combines the rich features of SQL with the scalability typically associated with NoSQL databases, enabling developers to innovate rapidly without compromising on consistency. The platform is trusted by major enterprises across various sectors, including finance, retail, and media.

Dialpad

Series F in 2021
Dialpad is an AI-powered cloud communications platform that turns conversations into opportunities and helps teams make smart calls. The communications and contact center provider offers native, real-time transcription, automated note-taking, live sentiment, and voice analytics to market, and with the rising demand for remote collaboration. It offers Dialpad, Dialpad Sell, UberConference, and Dialpad Contact Center solutions that are all powered by VoiceAI. These products cover the full range of modern business communications needs with a range of system software that offers voice, video, group messaging, SMS, MMS, conferencing, screen sharing, and document sharing services that enable employees to collaborate securely from anywhere across any device, in a single platform.

Wonder

Series A in 2021
Wonder is a gaming company focused on creating an all-in-one gaming platform for Android mobile devices. The platform enables users to play, stream, and share games seamlessly across various devices, thereby enhancing the overall gaming experience. In addition to its software solutions, Wonder is also involved in developing VR-ready gaming hardware. Currently, the company operates in stealth mode, suggesting that it is in the early stages of development and may be working on innovative features or products.

Universe

Series B in 2021
Universe is a mobile app that provides electric internet to build sites, shops, and portfolios. They also provide a payment block that allows them to sell products and accept payments online. They offer an order management system to help money flow.

Quartet Health

Corporate Round in 2021
Quartet is a platform that makes it easier for people to get the best mental health care for them. The best care should fit their preferences and clinical needs, take their insurance, and link to the rest of their healthcare experience. Quartet was founded in 2014 and is based in New York, United States.

Groundswell

Seed Round in 2021
Groundswell provides a SaaS platform for philanthropic giving, which enables companies to fund personal donor-advised funds for each employee. Employee users are also provided with tools such as tax-free investment opportunities, customized giving opportunities, frictionless donation options, and centralized impact reporting.

Upbound

Series B in 2021
Powered by Crossplane, Upbound is democratizing the best-kept secret in cloud computing — the control plane — giving platform engineers control and self-service. Upbound's flagship product is a single, global platform to build, deploy, and operate your own internal developer platforms using managed control planes powered by Crossplane. Upbound also offers Universal Crossplane (UXP) with security, support and official providers. The company was founded in 2017 and is fully remote, with roots in Seattle, Washington. Learn more at https://www.upbound.io/why-upbound.

Vercel

Series D in 2021
Vercel Inc. is a cloud platform that specializes in on-demand deployment, hosting, and sharing services for frontend applications. Founded in 2015 and based in Walnut, California, the company provides automated deployment solutions integrated with GitHub, Bitbucket, and GitLab, allowing projects to be deployed seamlessly from pull requests and merge requests. Vercel's platform is designed to enhance the development and deployment experience for frontend teams by hosting static websites and serverless functions that align with the Jamstack deployment model. This model ensures that web pages are pre-rendered and can be efficiently served by a content delivery network, delivering optimal performance for developers. Vercel was formerly known as ZEIT, Inc. before rebranding in April 2020.

Mabl

Series C in 2021
Mabl is an intelligent test automation company that helps software development teams to create a culture of quality by tightly integrating automated end-to-end testing into the entire CI/CD development lifecycle. Its users benefit from a unified platform for easily creating, executing, and maintaining auto-healing, reliable tests that result in faster delivery of high-quality applications. The company was co-founded by Dan Belcher and Izzy Azeri in 2017 and is headquartered in Boston, Massachusetts,

Farmers Business Network

Series G in 2021
Farmer Business Network (FBN) is an independent agronomic information network designed to enhance the livelihoods of farmers by making data accessible and useful. Leveraging data science and machine learning, FBN offers its members unbiased insights about their fields, drawing on billions of data points collected from a vast network of farmers. The platform provides valuable resources such as product performance analytics, benchmarking, and predictive insights based on real-world agricultural data. By connecting farmers across the United States, FBN helps them achieve input savings, gain profitable insights, and secure better crop prices, ultimately fostering a collaborative environment that benefits the agricultural community.

Ankyra

Series B in 2021
Ankyra is a biotech company developing anchored immunotherapy for cancer treatments. Systemic dosing of these potent immune stimulants is restricted due to widespread immune activation and toxicity. When cytokines are injected into tumor tissue, they localize specifically and persistently, causing intense hot spots of inflammation that activate an anti-tumor immune response. Ankyra used its Anchored Immunotherapy Platform to develop ANK-101, a stable complex of a modified IL-12 cytokine with aluminum hydroxide (Alhydrogel) to overcome the limitations of traditional cytokine therapeutics. Alhydrogel, an FDA-approved adjuvant for use in human and veterinary vaccines, acts as a scaffold to locally retain the potent activity of IL-12 after intratumoral administration, improving its therapeutic window. Ankyra's mission is to optimize the impact of anchored immunotherapy to improve the lives of patients with cancer.

Signos

Series A in 2021
Signos is on a mission to tackle the obesity epidemic via healthy habits, glucose level stabilization, and AI. Signos combines continuous glucose information with an AI-enhanced app to offer revolutionary continuous data and recommendations designed to drive healthy and sustained weight loss. With over 75% of the American population overweight or obese, Signos provides a new way for people to act on their body’s unique response to what they eat to lose weight and kickstart a healthier life

Yellowbrick Data

Series C in 2021
Yellowbrick Data was founded in 2014 by experts in database and flash memory technologies to simplify data warehousing. They wanted to solve the challenges of high availability, running complex mixed workloads, support for ad-hoc SQL, computing correct answers on any schema, massive scalability and supporting large numbers of concurrent users. Yellowbrick Data empowers companies to make faster decisions with all of their data. Built for enterprises and the hybrid cloud, the Yellowbrick Data Warehouse deploys powerful analytics anywhere, with best-in-class economics.

Antiva Biosciences

Series D in 2021
Antiva Biosciences is a biopharmaceutical company developing novel, localized therapeutics for the treatment of diseases caused by HPV infection. They aim to prevent cancer by treating precancerous lesions caused by HPV. Their programs are in clinical trials for high-grade anal intraepithelial neoplasias (AIN 2,3) and high-grade cervical intraepithelial neoplasias (CIN 2,3).

Patina

Series A in 2021
We believe everyone should have the opportunity to live their best lives and age with dignity. That’s why we’re reinventing primary care with an approach designed to profoundly improve the healthcare and aging experience for older adults and their loved ones.

Flock Freight

Series D in 2021
Flock Freight is reimagining and reinventing the freight industry by relentlessly eliminating inefficiency and waste through algorithmic pooling. Working at the intersection of cutting-edge technology and human-centric logistics management, Flock Freight tailors its shipping experience to meet your business’s needs. Flock Freight seamlessly pools any freight to find the perfect route, avoiding terminals and risky offloads so that a shipment travels safely and directly to its destination, damage-free. The result: on-time delivery with every shipment—guaranteed. With venture capital from Google Ventures and SignalFire, Flock Freight is one of the largest startups in San Diego, California. The company's team is obsessed with aggressively growing its customer base, constantly improving the technology platform, and delivering a superior customer experience. Flock Freight aims to fundamentally change the $60 billion LTL freight industry across North America with FlockDirect—one pooled shipment at a time.

Modern Age

Series A in 2021
Modern Age is a health & wellness platform that makes the journey of aging easier, healthier, and manageable by one own self.

RightHand Robotics

Venture Round in 2021
RightHand Robotics provides end-to-end solutions that reduce the cost of e-commerce order-fulfillment of electronics, apparel, grocery. Their robots grasp a wide variety of items from bins and cases. Their core technology enables them to do this automatically without laborious data entry or parameter-tuning — so they are inexpensive to set up and flexible to the changing needs of businesses. The company was founded in 2015 and is headquartered in Somerville, Massachusetts.

Sprinter Health

Series A in 2021
Sprinter Health is an on-demand mobile health company that sends full-time nurses and phlebotomists (“Sprinters”) into the home.

Matter

Series A in 2021
Matter is a social reading app for articles, blogs, and newsletters to help users find better content online.

IonQ

Post in 2021
IONQ develops general-purpose quantum information processors using a trapped ion approach. The method enables qubit replication, optical networkability, and optimized algorithms to support scalable quantum computing.

Agtonomy

Seed Round in 2021
Agtonomy is a hybrid autonomous and tele-assist platform that specializes in advanced autonomous and AI solutions for agriculture. It focuses on addressing the pressing challenges of labor scarcity, sustainability, and shrinking profit margins faced by farmers. It partners with established equipment developers to transform tractors and agriculture machines into autonomous and remote-controlled equipment that is accessible to local farmers.

Ripple Foods

Series E in 2021
Ripple Foods specializes in making non-dairy milk with just as much protein as milk and half the sugar. Ripple has 8x the protein of almond milk and half the sugar of dairy milk. It’s high in bioavailable calcium (50% more than milk), potassium and provides a good source of omega-3s. It’s lower in calories than milk and best of all, it has the creamy, delicious texture our dairy-free friends are missing. No more thin, chalky almond/ soy/ cashew milk. It was founded in 2014 and headquartered in Emeryville, California.

Dapper Labs

Series D in 2021
Dapper Labs, the company behind NBA Top Shot, uses blockchain technology to bring NFTs and new forms of digital engagement to fans around the world. Since it was founded in 2018, Dapper Labs has given consumer enthusiasts a real stake in the game by bringing them closer to the brands they love, building engaged and exciting communities for them to contribute to, and producing new pathways for them to become creators themselves.

Altana

Series A in 2021
Altana Technologies transforms the world’s public and non-public data into an intelligent, shared map of the global supply chain. Enterprises, governments, and logistics providers connect to Altana Atlas to illuminate, collaborate, and build trust across their global business networks. Through Altana, organizations across the public and private sectors are building a more resilient, secure, inclusive, and sustainable globalization.

StrongDM

Series B in 2021
StrongDM helps organizations manage and secure access to critical infrastructure by using a zero-trust approach. The platform provides users with controlled access to databases, servers, and applications, while also giving administrators clear visibility and audit trails.

ROME Therapeutics

Series B in 2021
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome – vast stretches of uncharted genetic material that have long been dismissed as “junk DNA.” With several drug targets identified and multiple discovery programs underway, ROME is moving rapidly to leverage this new frontier in biology. To lead this exploration, ROME has assembled a team of world-class leaders across fields including oncology, immunology, virology and machine learning.

SingleStore

Series F in 2021
SingleStore is a provider of a database for operational analytics and cloud-native applications. It provides global enterprises with an intelligent database that works on any cloud on-premises or as a service runs transactions and analytics at the same time and lets clients promote their business through analytics and combine semi-structured data into a consolidated big data platform.

Genome Medical

Series C in 2021
Genome Medical is a national telegenomics technology, services, and strategy company bringing genomic medicine to everyday care. Through its nationwide network of genetic specialists and an efficient Genome Care DeliveryTM technology platform, we provide expert virtual genetic care for individuals and their families to improve health and well-being. They also help health care providers and their patients navigate the rapidly expanding field of genetics and utilize test results to understand the risk for disease, accelerate disease diagnosis, make informed treatment decisions and lower the cost of care.

Snorkel AI

Series C in 2021
Snorkel AI is an AI development platform that enables enterprises to build production AI applications using programmatic data labeling and curation. Developed at Stanford AI Lab, it leverages weak supervision and other techniques to accelerate data preparation, making AI development faster and more efficient. Trusted by leading organizations, Snorkel AI helps create specialized, high-quality AI models by transforming proprietary data into AI-ready datasets.

Sonoma Biotherapeutics

Series B in 2021
Sonoma Biotherapeutics is a company invloved the development of adoptive Treg therapies cell for autoimmune and degenerative diseases. Using next generation genome editing and target-specific cell therapy, Sonoma is focused on developing its best-in-class platform across the entire spectrum of Treg cell therapeutic capabilities. Founded by pioneers in Treg biology and cell therapy, the company brings together leading expertise and proprietary methodologies for the discovery and development of disease modifying and curative therapies.

FullStory

Series D in 2021
FullStory is a customer experience data app that captures customer experience data in one platform. Its tiny script unlocks pixel-perfect session playback, automatic insights, funnel analytics, and robust search and segmentation empowering everyone in an organization to help build an online experience for customers. The company was founded in 2014 and is headquartered in Atlanta, Georgia.

Ahana

Series A in 2021
Ahana focused on bringing PrestoDB-based ad hoc analytics offerings to market and working to foster growth and evangelize the Presto community. While Presto is in large-scale production deployment at large internet companies like Facebook, Uber, and Twitter, Ahana’s mission is to simplify ad hoc analytics for organizations of all shapes and sizes.

Neuralink

Series C in 2021
Neuralink develops a brain-machine interface that provides solutions for those with paralysis. Neuralink engages in the development of high-bandwidth brain-machine interfaces. It is driven to build devices that will help people with paralysis and invent new technologies that will expand their abilities and community.

Nym

Venture Round in 2021
Nym transforms revenue cycle management by fully automating the medical coding process. Our engine deciphers clinical language in patient charts and accurately assigns medical charge codes in seconds and with zero human intervention. By automating medical coding with Nym, healthcare providers can improve coding quality while significantly reducing the time and cost associated with medical coding. This ultimately ensures clinical and administrative teams can spend more time focused on patient care.

Norby

Seed Round in 2021
Norby is an audience relationship toolkit built for creators and brands.

TMRW Life Sciences

Series C in 2021
TMRW is a life sciences technology company setting new standards for transparency, safety, and accountability in IVF and cell management. TMRW's platform, the world's first automated cryo-management for eggs and embryos, provides a complete digital chain of custody fully integrated with a robotic storage and monitoring solution. This is in contrast to the manual and analog methods that have gone unchanged throughout the history of IVF. With TMRW's platform, clinics significantly reduce the chances of potentially devastating errors. The TMRW team includes celebrated innovators in fertility, embryology, cryo-management, automation, software development, and robotics. TMRW is founded by Joshua Abram, Alan Murray, and Dr. Jeffrey Port in 2018 and is based in New York, New York.

Xilis

Series A in 2021
Xilis is a biotechnology company that develops technologies to guide precision therapy for cancer patients and accelerate drug discovery. The company's platform enables diagnostics, drug screening, and scalable patient-derived models for drug discovery, enabling physicians and pharmaceutical companies to develop tailored treatments for patients by conducting drug screening.

Instawork

Series C in 2021
Instawork operates as a career marketplace for hospitality professionals. It is changing how traditional recruiting works for small businesses by turning the process into an automated matching solution. Its vision is to create economic opportunity for local businesses and professionals, globally. The company was founded in 2015 and is headquartered in San Francisco, California.

Physna

Series B in 2021
Physna is a geometric deep-learning and 3D search company that searches, compares, and analyzes 3D models. Physna also owns Thangs.com, the fastest-growing 3D community and the first 3D search engine. Physna is powering innovation in manufacturing by bridging the gap between physical objects and digital code. Over 70% of the economy is centered around physical goods, but less than 1% of software is capable of handling 3D data. Physna was founded on the principle that computers should be taught to “think” in 3D, and accurately describe the real, 3D world around us. By enabling 3D models to be treated and analyzed like other codes, Physna’s technology bridges the gap between the physical world and the digital world of software. By democratizing the ability to design, interact with and analyze 3D models of the world around them, more people will have the ability to create and drive innovation in product design, 3D printing, augmented and virtual reality, gaming, healthcare, and beyond. Physna was founded in 2015 and is based in Cincinnati, Ohio.

Kindbody

Series C in 2021
Kindbody is a fertility clinic network and family-building benefits provider for employers offering comprehensive virtual and in-person care. Kindbody's clinically-managed program includes fertility assessments and education, fertility preservation, genetic testing, in vitro fertilization (IVF), donor and surrogacy services, and adoption. Employers partner with Kindbody to provide their employees with financial, medical, and emotional support as they pursue parenthood. Kindbody is the trusted fertility benefits provider for more than 100 employers, covering more than 2.4 million lives. Many thousands more receive their fertility care directly from Kindbody throughout the country at Kindbody’s network of signature clinics, mobile clinics, and partner clinics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.